Acadian Asset Management
APEN

Acadian Asset Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Acadian Asset Management’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,241
Closed -$23K – 1910
2022
Q2 		$23K Buy
6,241
+1,698
+37% +$8.03K ﹤0.01% 1604
2022
Q1 		$27K Sell
4,543
-8,026
-64% -$48.9K ﹤0.01% 1540
2021
Q4 		$105K Buy
12,569
+2,701
+27% +$23.6K ﹤0.01% 1363
2021
Q3 		$87K Buy
+9,868
New +$84.8K ﹤0.01% 1480
2021
Q2 		– Sell
-10,169
Closed -$56K – 2282
2021
Q1 		$56K Buy
+10,169
New +$50.3K ﹤0.01% 1798

Other funds holding APEN

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Acadian Asset Management's APEN Position: Q3 2022 in Review

Acadian Asset Management sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2022, closing a stake of 6,241 shares — an estimated $23K sold.

Acadian Asset Management first reported a position in APEN in Q1 2021 and held it in 5 quarters. The position peaked at $105K in Q4 2021. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

  • Acadian Asset Management reported no remaining Apollo Endosurgery, Inc. position as of Q3 2022 after selling out during the quarter.
  • Acadian Asset Management sold 6,241 Apollo Endosurgery, Inc. shares in Q3 2022, an estimated $23K.
  • Acadian Asset Management first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and held it in 5 quarters.
  • Acadian Asset Management's Apollo Endosurgery, Inc. position peaked at $105K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on Acadian Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.